Source: Υπουργείο Υγείας (CY) Revision Year: 2019 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Medorphan 7.5mg/5ml oral solution.
Pharmaceutical Form |
---|
Oral solution. The solution is a slightly yellowish, transparent, clear, flavoured liquid. |
Medorphan contains 7.5 mg dextromethorphan hydrobromide Ph Eur in each 5 ml of oral solution.
Excipients with known effect: sucrose, sorbitol, liquid glucose and ethanol.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Demorphan |
Dextromethorphan is a non-opioid antitussive drug. The major metabolite of dextromethorphan, dextrorphan, binds with high affinity to σ-receptors to produce its antitussive activity without exhibiting the classic opiate effects that occur from binding into μ- and δ-receptors. In larger than therapeutic doses, dextrorphan is also an antagonist of N-methyl-D-aspartate (NMDA) receptors. |
List of Excipients |
---|
Saccharin Sodium, Sodium Benzoate, Sugar (Sucrose), Liquid Glucose, Sorbitol solution 70%, Glycerol, Absolute Ethanol, Levomenthol, Citric acid anhydrous, Caramel flavour (liquid), Peach flavour (liquid), Purified Water. |
150 ml and 200 ml Type III (Ph.Eur) brown glass bottles closed with caps (aluminium sheet; liner – EPE sealing disk: hot-foamed polyethylene).
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
21899
Date of first authorisation: 14/10/2013
Date of latest renewal: 26/09/2019
Drug | Countries | |
---|---|---|
MEDORPHAN | Cyprus |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.